ADPT

Adaptive Biotechnologies makes a test called clonoSEQ that detects cancer cells remaining in a patient's body after treatment. The company uses genetic sequencing and computer analysis to decode the immune system and look for signs of disease. They also sell tools and services to researchers and drug companies who study the immune system and develop new medicines.